Cryo-Cell International, Inc.CCELNYSE
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
356.06%
↑ 1764% above average
Average (39q)
19.10%
Historical baseline
Range
High:1979.74%
Low:-1744.23%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 356.06% |
| Q2 2025 | 25.78% |
| Q1 2025 | 115.19% |
| Q4 2024 | -277.01% |
| Q3 2024 | 60.37% |
| Q2 2024 | 17.90% |
| Q1 2024 | 104.97% |
| Q4 2023 | -1744.23% |
| Q3 2023 | 207.98% |
| Q2 2023 | -71.18% |
| Q1 2023 | -8.48% |
| Q4 2022 | 79.47% |
| Q3 2022 | -26.45% |
| Q2 2022 | -23.72% |
| Q1 2022 | 230.58% |
| Q4 2021 | -174.40% |
| Q3 2021 | -26.83% |
| Q2 2021 | 68.78% |
| Q1 2021 | -42.19% |
| Q4 2020 | 52.95% |
| Q3 2020 | -17.71% |
| Q2 2020 | 38.78% |
| Q1 2020 | -18.70% |
| Q4 2019 | -24.30% |
| Q3 2019 | 1979.74% |
| Q2 2019 | -80.54% |
| Q1 2019 | -69.03% |
| Q4 2018 | 263.60% |
| Q3 2018 | -54.59% |
| Q2 2018 | 121.32% |
| Q1 2018 | -472.50% |
| Q4 2017 | 4.17% |
| Q3 2017 | 31.21% |
| Q2 2017 | 2.06% |
| Q1 2017 | -39.84% |
| Q4 2016 | 130.61% |
| Q3 2016 | -515.04% |
| Q2 2016 | 618.26% |
| Q1 2016 | 43.98% |
| Q4 2015 | -102.80% |